Avenzo Therapeutics Strengthens Leadership Team
Avenzo Therapeutics Strengthens Executive Leadership With Appointments of Annie Chang and Aaron Hasnain Avenzo Therapeutics, Inc., a clinical-stage biotechnology company focused on developing next-generation oncology therapies, has expanded its executive…
Biodextris Names Clement Fourny as Chief Executive Officer
Biodextris Appoints Clement Fourny as CEO to Lead Next Phase of Biologics CDMO Growth Biodextris, a Laval, Quebec-based biologics contract development and manufacturing organization (CDMO), has appointed Clement Fourny as…
SCIEX Expands BioPhase 8800 System to Accelerate Therapeutic Development
SCIEX Expands BioPhase 8800 Capabilities to Support Faster, More Automated CE Workflows SCIEX, a Danaher company and a provider of analytical technologies for the life sciences, has announced new capillary…
Bayer’s Lynkuet Receives FDA Priority Review for Breast Cancer Therapy-Related Vasomotor Symptoms
Bayer’s Lynkuet Receives FDA Priority Review for Vasomotor Symptoms Associated With Breast Cancer Endocrine Therapy Bayer announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental…
Circle Pharma Promotes Marie Evangelista to CSO, Adds Mary Ellen Sillivos as HR Chief
Circle Pharma Strengthens Leadership Team to Advance Targeted Macrocycle Cancer Pipeline Circle Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation targeted macrocycle therapeutics for cancer, has announced two…
Bristol Myers Squibb Presents Phase 3 EXCALIBER-RRMM Results for ZENBEXUS Plus Daratumumab in Multiple Myeloma
Bristol Myers Squibb Reports Phase 3 EXCALIBER-RRMM Results Showing Higher MRD-Negative Responses With ZENBEXUS in Relapsed or Refractory Multiple Myeloma Bristol Myers Squibb (NYSE: BMY) has announced the first presentation…
Lōkahi Therapeutics Expands ai2 Pipeline Program Through Pepperdine E2B Collaboration
Lōkahi Therapeutics Expands ai2 Pipeline Program Through Partnership With Pepperdine E2B Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), has announced a new collaboration with Pepperdine E2B™ (Education to…
Austin Community Rallies for Susan G. Komen MORE THAN PINK Walk to Address Breast Cancer
Susan G. Komen to Host Austin MORE THAN PINK Walk to Support Breast Cancer Research and Patient Care Susan G. Komen®, a leading breast cancer organization, is preparing to host…
Quanterix Advances Spatial Biology Innovation at ESSB 2026
Quanterix Advances Spatial Biology Content Innovation Engine With New Cancer Research Tools Quanterix Corporation (NASDAQ: QTRX) has reported further progress on its Content Innovation Engine, a strategic initiative introduced at…
Alume Biosciences’ Bevonescein Receives FDA Breakthrough Therapy Designation
Alume Biosciences Receives FDA Breakthrough Therapy Designation for Bevonescein in Intraoperative Nerve Visualization Alume Biosciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation…
Aptar Pharma and Macquarie University Partner to Advance Inhaled Biologics Research
Aptar Pharma and Macquarie University Launch Research Program to Advance Inhaled Biologic Delivery Aptar Pharma, a global provider of drug delivery, dosing and protection technologies and services, has announced a…
FDA Approves WELIREG Plus LENVIMA for Previously Treated Advanced ccRCC
FDA Approves WELIREG Plus LENVIMA for Previously Treated Advanced Clear Cell Renal Cell Carcinoma Merck, known as MSD outside the United States and Canada, and Eisai announced that the U.S.…